Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants

Clinical Trial ID NCT00106925

PubWeight™ 6.27^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00106925

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts.	Am J Hematol	1997	1.27
2	Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome.	Haematologica	2010	1.23
3	Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias.	Lancet	1987	1.22
4	Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients.	Br J Haematol	2001	1.19
5	Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation--implications for screening and HPV vaccination.	Biol Blood Marrow Transplant	2008	1.11
6	Male survivors of allogeneic hematopoietic stem cell transplantation have a long term persisting risk of cardiovascular events.	Exp Hematol	2013	0.98
7	Prolonged chronic graft-versus-host disease is a risk factor for thyroid failure in long-term survivors after matched sibling donor stem cell transplantation for hematologic malignancies.	Biol Blood Marrow Transplant	2009	0.84
8	Evolution of the donor T-cell repertoire in recipients in the second decade after allogeneic stem cell transplantation.	Blood	2011	0.79
9	Repair of impaired pulmonary function is possible in very-long-term allogeneic stem cell transplantation survivors.	Biol Blood Marrow Transplant	2013	0.76
10	Factors influencing the late phase of recovery after bone mineral density loss in allogeneic stem cell transplantation survivors.	Bone Marrow Transplant	2016	0.75